Skip to main content
Erschienen in: NeuroTransmitter 4/2012

20.04.2012 | Zertifizierte Fortbildung

Wenn Paresen die Arme lähmen

Multifokale motorische Neuropathie

verfasst von: Kathrin Doppler, Prof. Dr. med. Claudia Sommer

Erschienen in: NeuroTransmitter | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die multifokale motorische Neuropathie (MMN) ist eine rein motorische Neuropathie, bei der die Paresen und Atrophien typischerweise dem Verteilungsmuster einzelner peripherer Nerven folgen, die gut auf eine Therapie mit hochdosierten humanen Immunglobulinen ansprechen.

Literatur
  1. Roth G, Rohr J, Magistris MR, Ochsner F. Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia. Evolution to tetraplegia. Eur Neurol 1986;25(6):416–423.PubMedView Article
  2. Pestronk A, Cornblath DR, Ilyas AA, Baba H, Quarles RH, Griffin JW, Alderson K, Adams RN. A treatable multifocal motor neuropathy with anti-bodies to GM1 ganglioside. Annals of neurology 1988;24(1):73–78.PubMedView Article
  3. Taylor BV, Wright RA, Harper CM, Dyck PJ. Natural history of 46 patients with multifocal motor neuropathy with conduction block. Muscle Nerve 2000;23(6):900–908.PubMedView Article
  4. Cats EA, van der Pol WL, Piepers S, Franssen H, Jacobs BC, van den Berg-Vos RM, Kuks JB, van Doorn PA, van Engelen BG, Verschuuren JJ, Wokke JH, Veldink JH, van den Berg LH. Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy. Neurology 2010;75(9):818–825.PubMedView Article
  5. Meuth SG, Kleinschnitz C. Multifocal motor neuropathy: update on clinical characteristics, pathophysiological concepts and therapeutic options. Eur Neurol 2010;63(4):193–204.PubMedView Article
  6. Nobile-Orazio E, Cappellari A, Priori A. Multifocal motor neuropathy: current concepts and controversies. Muscle Nerve 2005;31(6):663–680.PubMedView Article
  7. Bouche P, Moulonguet A, Younes-Chennoufi AB, Adams D, Baumann N, Meininger V, Leger JM, Said G. Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry 1995;59(1):38–44.PubMedView Article
  8. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision. J Peripher Nerv Syst 2010;15(4):295–301.View Article
  9. Sutedja NA, Otten HG, Cats EA, Piepers S, Veldink JH, van der Pol WL, van den Berg LH. Increased frequency of HLA-DRB1*15 in patients with multifocal motor neuropathy. Neurology 2010;74(10):828–832.PubMedView Article
  10. Cats EA, Bertens AS, Veldink JH, van den Berg LH, van der Pol WL. Associated autoimmune diseases in patients with multifocal motor neuropathy and their family members. J Neurol 2011.
  11. Van Asseldonk JT, Franssen H, Van den Berg-Vos RM, Wokke JH, Van den Berg LH. Multifocal motor neuropathy. Lancet Neurol 2005;4(5):309–319.PubMedView Article
  12. Taylor BV, Dyck PJ, Engelstad J, Gruener G, Grant I. Multifocal motor neuropathy: pathologic alterations at the site of conduction block. J Neuropathol Exp Neurol 2004;63(2):129–137.PubMed
  13. Kaji R, Oka N, Tsuji T, Mezaki T, Nishio T, Akiguchi I, Kimura J. Pathological findings at the site of conduction block in multifocal motor neuropathy. Annals of neurology 1993;33(2):152–158.PubMedView Article
  14. Uetz-von Allmen E, Sturzenegger M, Rieben R, Rihs F, Frauenfelder A, Nydegger UE. Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controls. Eur Neurol 1998;39(2):103–110.PubMedView Article
  15. Santoro M, Uncini A, Corbo M, Staugaitis SM, Thomas FP, Hays AP, Latov N. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Annals of neurology 1992;31(4):385–390.PubMedView Article
  16. Uncini A, Santoro M, Corbo M, Lugaresi A, Latov N. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve 1993;16(6):610–615.PubMedView Article
  17. Yuki N, Watanabe H, Nakajima T, Spath PJ. IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 2011;82(1):87–91.PubMedView Article
  18. Piepers S, Jansen MD, Cats EA, van Sorge NM, van den Berg LH, van der Pol WL. IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN. J Neuroimmunol 2010;229(1–2):256–262.PubMedView Article
  19. Van Asseldonk JT, Van den Berg LH, Van den Berg-Vos RM, Wieneke GH, Wokke JH, Franssen H. Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness. Brain 2003;126(Pt 1):186–198.PubMedView Article
  20. Kuijf ML, van Doorn PA, Tio-Gillen AP, Geleijns K, Ang CW, Hooijkaas H, Hop WC, Jacobs BC. Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA. J Neurol Sci 2005;239(1):37–44.PubMedView Article
  21. Van Es HW, Van den Berg LH, Franssen H, Witkamp TD, Ramos LM, Notermans NC, Feldberg MA, Wokke JH. Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy. Neurology 1997;48(5):1218–1224.PubMed
  22. Beekman R, van den Berg LH, Franssen H, Visser LH, van Asseldonk JT, Wokke JH. Ultrasonography shows extensive nerve enlargements in multifocal motor neuropathy. Neurology 2005;65(2):305–307.PubMedView Article
  23. Lewis RA. Multifocal motor neuropathy and Lewis Sumner syndrome: two distinct entities. Muscle Nerve 1999;22(12):1738–1739.PubMedView Article
  24. Viala K, Renie L, Maisonobe T, Behin A, Neil J, Leger JM, Bouche P. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain 2004;127(Pt 9):2010–2017.PubMedView Article
  25. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-First Revision. J Peripher Nerv Syst 2010;15(1):1–9.View Article
  26. Niebroj-Dobosz I, Jamrozik Z, Janik P, Hausmanowa-Petrusewicz I, Kwiecinski H. Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients. Acta Neurol Scand 1999;100(4):238–243.PubMedView Article
  27. Sederholm BH. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome. Semin Neurol 2010;30(4):443–456.PubMedView Article
  28. Nobile-Orazio E. Multifocal motor neuropathy. J Neuroimmunol 2001;115(1–2):4–18.PubMedView Article
  29. van Schaik IN, van den Berg LH, de Haan R, Vermeulen M. Intravenous immunoglobulin for multifocal motor neuropathy. Cochrane Database Syst Rev 2005(2):CD004429.PubMed
  30. Leger JM, Chassande B, Musset L, Meininger V, Bouche P, Baumann N. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study. Brain 2001;124(Pt 1):145–153.PubMedView Article
  31. Azulay JP, Blin O, Pouget J, Boucraut J, Bille-Turc F, Carles G, Serratrice G. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study. Neurology 1994;44(3 Pt 1):429–432.PubMed
  32. Federico P, Zochodne DW, Hahn AF, Brown WF, Feasby TE. Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study. Neurology 2000;55(9):1256–1262.PubMed
  33. Harbo T, Andersen H, Hess A, Hansen K, Sindrup SH, Jakobsen J. Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial. Eur J Neurol 2009;16(5):631–638.PubMedView Article
  34. Eftimov F, Vermeulen M, de Haan RJ, van den Berg LH, van Schaik IN. Subcutaneous immunoglobulin therapy for multifocal motor neuropathy. J Peripher Nerv Syst 2009;14(2):93–100.PubMedView Article
  35. Harbo T, Andersen H, Jakobsen J. Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy. Neurology 2010;75(15):1377–1380.PubMedView Article
  36. Piepers S, Van den Berg-Vos R, Van der Pol WL, Franssen H, Wokke J, Van den Berg L. Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial. Brain 2007;130(Pt 8):2004–2010.PubMedView Article
  37. Chaudhry V, Cornblath DR. An open-label trial of rituximab (Rituxan(R)) in multifocal motor neuropathy. J Peripher Nerv Syst 2010;15(3):196–201.PubMedView Article
Metadaten
Titel
Wenn Paresen die Arme lähmen
Multifokale motorische Neuropathie
verfasst von
Kathrin Doppler
Prof. Dr. med. Claudia Sommer
Publikationsdatum
20.04.2012
Verlag
Urban and Vogel
Erschienen in
NeuroTransmitter / Ausgabe 4/2012
Print ISSN: 1436-123X
Elektronische ISSN: 2196-6397
DOI
https://doi.org/10.1007/s15016-012-0115-6

Weitere Artikel der Ausgabe 4/2012

NeuroTransmitter 4/2012 Zur Ausgabe

Die Verbände informieren

SPD will bei IGeL bremsen

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.